Eli Lilly and Company (Lilly) will construct an active pharmaceutical ingredient (API) manufacturing facility in Harris County, totaling around 1 million square feet. Lilly will invest more than $6.5 billion. A Texas Enterprise Fund (TEF) grant of $5.5 million has been extended to Lilly.
The new site in Harris County will focus on domestic production of next-generation small-molecule synthetic medicines. The plant will focus on orforglipron, a small molecule that it is developing as a treatment for type 2 diabetes and weight loss.Â
Eli Lilly said the site will bring 615 jobs to the Greater Houston area, including highly skilled engineers, scientists, operations personnel and lab technicians, and 4,000 construction jobs. Additionally, for every job created in manufacturing, several more will be created in related sectors such as supply chain, logistics and retail.
This is the largest investment in API manufacturing in Texas to date. Lilly stressed that the move was necessary to avoid tariffs on foreign-made drugs.
The post Lilly Investing $6.5B in Houston Manufacturing Facility appeared first on Connect CRE.
​Â